GSK-J4 - H3K27 Histone Demethylases UTX and JMJD3 Inhibitor. CAS# 1373423-53-0 6050 AZD2014 shows consistent exposure in

AZD2014 shows consistent exposure in rodents and a low turnover in human hepatocyte incubations

CAS Number: 912545-86-9

MM-102 specifically reduces expression of two critical MLL1 target genes (HoxA9 and Meis-1)

InChi: InChI=1S/C31H38N6O2/c1-6-22(5)37-18-20(3)29-25(30(38)34-17-26-19(2)13-21(4)35-31(26)39)14-24(15-27(29)37)23-7-8-28(33-16-23)36-11-9-32-10-12-36/h7-8

Epub 2012 Aug 24

GSK-J4 - H3K27 Histone Demethylases UTX and JMJD3 Inhibitor. CAS# 1373423-53-0 6050 AZD2014 shows consistent exposure inGSK J4, CAS No. 1373423 53 0, is an ethyl ester derivative of GSK J1, which is the first selective and potent inhibitor of the H3K27 histone demethylases UTX and JMJD3. The highly polar carboxylate group of GSK J1 restricts its cellular permeability, therefore GSK J4 was developed as a pro drug, masking the polarity of the acid group of the GSK J1, for cellular assays. GSK J4 could significant reduce LPS induced pro inflammatory cytokine production in